IL6 and breast carcinoma: Moreover, in a murine model of orthotopic 4T1 breast cancer, DOX-INH suppressed Shh, IL-6, and TGF-β signaling pathways and thus mitigated EMT and the growth and metastasis of breast cancer cells [120].